Prostaglandin I2 reduces activation of human arterial smooth muscle cells in-vivo. 1987

H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
Atherosclerosis Research Group (ASF) Vienna, Austria.

Patients suffering from peripheral vascular disease have been "ultima ratio"-treated with PGI2 at a rate of 5 ng/kg/min for 6 hours a day and 5 consecutive days i.v. 20 of them underwent surgery thereafter as therapy was not sufficient. A histological examination and quantification of vascular tissue revealed that the number of activated smooth muscle cells was significantly lower in treated patients vascular segments than in untreated ones in all the different age groups. A comparable suppression was found in the intima and the media as well. It is thus concluded, that PGI2 inhibits smooth muscle cell proliferation most probably by inhibiting PDGF-release from the platelets and stimulation of smooth muscle cell cAMP. To achieve a more beneficial PGI2-effect at the vascular level, a prolonged PGI2-therapy looks rather promising.

UI MeSH Term Description Entries
D008297 Male Males
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001158 Arteries The vessels carrying blood away from the heart. Artery
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease

Related Publications

H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
July 1986, Lancet (London, England),
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
May 1983, The Journal of biological chemistry,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
August 1994, The American journal of physiology,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
May 2013, International journal of cardiology,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
August 2017, British journal of pharmacology,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
April 1987, Japanese circulation journal,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
September 1988, Atherosclerosis,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
June 1988, Atherosclerosis,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
September 1996, Nihon Jinzo Gakkai shi,
H Sinzinger, and T Zidek, and P Fitscha, and J O'Grady, and O Wagner, and J Kaliman
January 2000, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica,
Copied contents to your clipboard!